Newsletter Archive

  1. 10.14.25 -- Discovery On Hold: How Shutdowns Stall Science And Shake Trust 10/14/2025
    10/14/25
  2. 10.07.25 -- Novel Preclinical Models To Advance Oncology Therapeutics 10/7/2025

    10/07/25 Drug Discovery Online Newsletter

  3. 10.07.25 -- Tyra Crystallizing The First Oral FGFR3 Therapy For Achondroplasia 10/7/2025
    10/07/25 Drug Discovery Online Newsletter
  4. AI Meets Aging: Inside The Longevity Revolution 9/30/2025
    [UNSCHEDULED]
  5. 09.25.25 -- 6 Key Resources For Innovative Preclinical Drug Development 9/25/2025

    09/25/25 Drug Discovery Online Newsletter

  6. 09.23.25 -- The Evolving Landscape Of Drug Discovery Services 9/23/2025

    09/23/25 Drug Discovery Online Newsletter

  7. 09.18.25 -- Protein Degradation: PROTACs, Molecular Glues, And Other Emerging Trends 9/18/2025

    09/18/25 Drug Discovery Online Newsletter

  8. 09.16.25 -- From Discovery To Delivery: Accelerating The Path Forward For Gene Therapies 9/16/2025
    09/16/25 Drug Discovery Online Newsletter
  9. 09.09.25 -- TYK2 Inhibition Emerges As A Next-Gen Strategy To Treat PsA 9/9/2025
    09/09/25 Drug Discovery Online Newsletter
  10. 09.04.25 -- Learn how to enhance productivity in your monoclonal antibody (mAb) capture process 9/4/2025

    09/04/25 Drug Discovery Online Newsletter